Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ: INDV · Real-Time Price · USD
39.80
-0.45 (-1.12%)
At close: Jul 2, 2026, 4:00 PM EDT
40.59
+0.79 (1.98%)
After-hours: Jul 2, 2026, 6:16 PM EDT
Indivior Pharmaceuticals Employees
As of December 31, 2025, Indivior Pharmaceuticals had 838 total employees, including 827 full-time and 11 part-time employees. The number of employees decreased by 213 or -20.27% compared to the previous year.
Employees
838
Change
-213
Growth
-20.27%
Revenue / Employee
$1,539,379
Profits / Employee
$300,716
Market Cap
4.85B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 838 | -213 | -20.27% | 827 | 11 |
| Jun 30, 2025 | 1,000 | 0 | - | 1,000 | 0 |
| Dec 31, 2024 | 1,051 | -113 | -9.71% | 1,030 | 21 |
| Sep 30, 2024 | 1,000 | 0 | - | 1,000 | 0 |
| Jun 30, 2024 | 1,000 | 0 | - | 1,000 | 0 |
| Mar 31, 2024 | 1,000 | 0 | - | 1,000 | 0 |
| Dec 31, 2023 | 1,164 | 236 | 25.43% | 1,164 | 0 |
| Sep 30, 2023 | 1,000 | 100 | 11.11% | 1,000 | 0 |
| Jun 30, 2023 | 1,000 | 100 | 11.11% | 1,000 | 0 |
| Mar 31, 2023 | 1,000 | 200 | 25.00% | 1,000 | 0 |
| Dec 31, 2022 | 928 | 43 | 4.86% | 928 | 0 |
| Sep 30, 2022 | 900 | 100 | 12.50% | 900 | 0 |
| Jun 30, 2022 | 900 | 100 | 12.50% | 900 | 0 |
| Mar 31, 2022 | 800 | 12 | 1.52% | 800 | 0 |
| Dec 31, 2021 | 885 | 97 | 12.31% | 885 | 0 |
| Sep 30, 2021 | 800 | 12 | 1.52% | 800 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,527 |
| Amneal Pharmaceuticals | 8,700 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| Lantheus Holdings | 1,193 |
| Prestige Consumer Healthcare | 890 |
| Supernus Pharmaceuticals | 778 |
| BioCryst Pharmaceuticals | 435 |
INDV News
- 15 days ago - Indivior initiated with an Overweight at Barclays - TheFly
- 6 weeks ago - Indivior reports real-world data for Sublocade in opioid use disorder - TheFly
- 6 weeks ago - New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization - GlobeNewsWire
- 7 weeks ago - Indivior to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Indivior announces $175M accelerated share repurchase program - TheFly
- 2 months ago - Indivior Announces $175 Million Accelerated Share Repurchase - GlobeNewsWire
- 2 months ago - Indivior reports Q1 EPS 96c, consensus 66c - TheFly
- 2 months ago - Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance - GlobeNewsWire